Filana Therapeutics, Inc. SEC filings FLNA
Filana Therapeutics, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Nov 9, 2006. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 11, 2026 |
| DEF 14A | Proxy statement | Apr 14, 2025 | May 23, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 3, 2025 | May 23, 2025 |
| DEF 14A | Proxy statement | Mar 26, 2024 | May 9, 2024 |
| DEF 14A | Proxy statement | Mar 27, 2023 | — |
| PRE 14A | Preliminary proxy statement | Mar 16, 2023 | — |
| DEF 14A | Proxy statement | Mar 24, 2022 | Dec 31, 2021 |
| DEF 14A | Proxy statement | Mar 31, 2021 | Dec 31, 2020 |
| DEF 14A | Proxy statement | Mar 26, 2020 | Mar 26, 2020 |
| DEF 14A | Proxy statement | Mar 29, 2019 | Mar 29, 2019 |
| DEF 14A | Proxy statement | Mar 27, 2018 | Mar 26, 2018 |
| PRE 14A | Preliminary proxy statement | Mar 16, 2018 | Mar 16, 2018 |
| DEFA14A | Additional proxy material | Mar 29, 2017 | — |
| DEF 14A | Proxy statement | Mar 21, 2017 | Mar 20, 2017 |
| PRE 14A | Preliminary proxy statement | Mar 9, 2017 | Dec 31, 2016 |
| DEF 14A | Proxy statement | Apr 14, 2016 | Apr 13, 2016 |
| DEF 14A | Proxy statement | Apr 7, 2015 | Apr 7, 2015 |
| DEF 14A | Proxy statement | Apr 7, 2014 | Apr 7, 2014 |
| DEF 14A | Proxy statement | Apr 5, 2013 | May 16, 2013 |
| DEF 14A | Proxy statement | Apr 4, 2012 | May 17, 2012 |
| DEF 14A | Proxy statement | Apr 8, 2011 | May 19, 2011 |
| DEF 14A | Proxy statement | Apr 7, 2010 | May 20, 2010 |
| DEF 14A | Proxy statement | Apr 6, 2009 | May 21, 2009 |
| DEF 14A | Proxy statement | Apr 7, 2008 | May 22, 2008 |
| DEF 14A | Proxy statement | Apr 11, 2007 | May 24, 2007 |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- FLNA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Austin, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1069530
- Former names
- CASSAVA SCIENCES INC (until Feb 19, 2026); PAIN THERAPEUTICS INC (until Mar 25, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.